U.S. markets closed

TruTrace Technologies Inc. (TTTSF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0460+0.0010 (+2.22%)
At close: 3:46PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0450
Open0.0492
BidN/A x N/A
AskN/A x N/A
Day's Range0.0450 - 0.0497
52 Week Range0.0264 - 0.1849
Volume203,331
Avg. Volume81,197
Market Cap6.02M
Beta (5Y Monthly)4.12
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Nauticol Energy and Enhance Energy partner to capture up to one million tonnes of CO2 annually from Blue Methanol production and distribution business
    CNW Group

    Nauticol Energy and Enhance Energy partner to capture up to one million tonnes of CO2 annually from Blue Methanol production and distribution business

    CALGARY, AB, March 23, 2021 /CNW/ - Nauticol and Enhance have entered into an agreement to work collaboratively for the capture and sequestration of up to one million tonnes of CO2 each year from Nauticol's planned Blue Methanol facility to be built near Grande Prairie, Alberta.Nauticol is building a world scale methanol production and distribution business to supply the unmet and rapidly growing global demand for low carbon methanol.

  • Business Wire

    TruTrace Technologies Joins Forces with Customer Engagement Expert PharmaCentra to Provide a Blockchain-Secured Ecosystem for Medical Cannabis

    TruTrace Technologies (CSE: TTT; OTCQB: TTTSF), developer of a fully-integrated blockchain platform for the legal cannabis, food, and pharmaceutical industries, today announced that it has signed a letter of intent (LOI) with Georgia-based PharmaCentra LLC – through its subsidiary CannabisBPO -- to support a clinical trial ecosystem built on standardized protocols and testing of cannabis products for use in the medical industry.

  • Applied DNA and TruTrace Technologies™ Unveil Complete Cannabis Product Validation and Authentication Solution
    Business Wire

    Applied DNA and TruTrace Technologies™ Unveil Complete Cannabis Product Validation and Authentication Solution

    Applied DNA Sciences, Inc. (NASDAQ: APDN) (the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the signing of a definitive agreement with TruTrace Technologies, Inc. (CSE: TTT) ("TruTrace"), developer of a fully-integrated blockchain platform for the legal cannabis, food and pharmaceutical industries, to approach the cannabis industry with an integrated solution comprised of Applied DNA’s CertainT® platform and TruTrace’s StrainSecure™ platform to deliver a complete cannabis product validation and authentication platform differentiated in the marketplace by linking together the power of proprietary SaaS platforms, blockchain and molecular tagging technology to create a secure ecosystem which provides end-to-end traceability and full transparency.